We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00379613
Recruitment Status : Completed
First Posted : September 22, 2006
Last Update Posted : August 22, 2017
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.